Loading

Muscle Invasive Urothelial Carcinoma

Neoadjuvant Atezolizumab Associated With High DFS in Muscle-Invasive Bladder Cancer

The multicenter, single-arm, phase 2 trial was conducted by Bernadett Szabados, MD, of the Queen Mary University of London and University College London Hospitals National Health Center Foundation Trust, and colleagues. The results were published in European Urology. ...

Advertisement

Latest News

Advertisement

Urothelial Carcinoma Knowledge Hubs

Curated clinical content based on urothelial cancer types, therapies, and technologies

Urothelial Carcinoma
Urothelial Carcinoma

Conference Coverage

Advertisement
Advertisement
Trending

Emily Menendez

RLT-PSMA | August 18, 2022

The first PET scans using Illuccix, Telix’s PSMA-PET imaging agent, have been carried out in cooperation with BAMF Health.

Emily Menendez

RLT-PSMA | August 18, 2022

Nanobubbles can target membrane proteins, including PSMA, to bind to receptors that are overexpressed in cancer cells.

Few biomarkers predict therapeutic response to radiation or adjunctive treatments in PCa patients treated with radiotherapy.